Literature DB >> 19554336

[New aspects in the area of spondyloarthritis. Report on the 6(th) International Congress on Spondyloarthropathies].

U Kiltz1, M Rudwaleit, J Sieper, J Braun.   

Abstract

The concept of genetic principles and the pathophysiologic relationship in the course of spondyloarthropathies, especially in ankylosing spondylitis, has been strengthened significantly by a body of recent scientific data. These novel aspects have been presented at the 6(th) International Congress on Spondyloarthropathies in Ghent (October, 2(nd) - 4(th) 2008).

Entities:  

Mesh：

Year:  2009        PMID： 19554336     DOI： 10.1007/s00393-009-0491-x

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN： 0340-1855            Impact factor:   1.372


  11 in total

1.  Tumour necrosis factor blockers and structural remodelling in ankylosing spondylitis: what is reality and what is fiction?

Authors:  Georg Schett; Robert Landewé; Désirée van der Heijde
Journal:  Ann Rheum Dis       Date:  2007-06       Impact factor: 19.103

Review 2.  Critical appraisal of assessment of structural damage in ankylosing spondylitis: implications for treatment outcomes.

Authors:  Joachim Sieper; Heiner Appel; Jürgen Braun; Martin Rudwaleit
Journal:  Arthritis Rheum       Date:  2008-03

Review 3.  Induction and effector functions of T(H)17 cells.

Authors:  Estelle Bettelli; Thomas Korn; Mohamed Oukka; Vijay K Kuchroo
Journal:  Nature       Date:  2008-06-19       Impact factor: 49.962

4.  Assessment of acute spinal inflammation in patients with ankylosing spondylitis by magnetic resonance imaging: a comparison between contrast enhanced T1 and short tau inversion recovery (STIR) sequences.

Authors:  X Baraliakos; K-G A Hermann; R Landewé; J Listing; W Golder; J Brandt; M Rudwaleit; M Bollow; J Sieper; D van der Heijde; J Braun
Journal:  Ann Rheum Dis       Date:  2005-01-13       Impact factor: 19.103

5.  Time-dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonists.

Authors:  Johan Askling; C Michael Fored; Lena Brandt; Eva Baecklund; Lennart Bertilsson; Nils Feltelius; Lars Cöster; Pierre Geborek; Lennart T Jacobsson; Staffan Lindblad; Jörgen Lysholm; Solbritt Rantapää-Dahlqvist; Tore Saxne; Ronald F van Vollenhoven; Lars Klareskog
Journal:  Ann Rheum Dis       Date:  2007-01-29       Impact factor: 19.103

6.  Malignancy and biologic therapy in rheumatoid arthritis.

Authors:  Johan Askling; Tim Bongartz
Journal:  Curr Opin Rheumatol       Date:  2008-05       Impact factor: 5.006

7.  MRI in predicting a major clinical response to anti-tumour necrosis factor treatment in ankylosing spondylitis.

Authors:  M Rudwaleit; S Schwarzlose; E S Hilgert; J Listing; J Braun; J Sieper
Journal:  Ann Rheum Dis       Date:  2007-11-15       Impact factor: 19.103

Review 8.  Breakthroughs in genetic studies of ankylosing spondylitis.

Authors:  M A Brown
Journal:  Rheumatology (Oxford)       Date:  2007-11-22       Impact factor: 7.580

9.  Overcoming drug resistance induced by P-glycoprotein on lymphocytes in patients with refractory rheumatoid arthritis.

Authors:  S Tsujimura; K Saito; M Nawata; S Nakayamada; Y Tanaka
Journal:  Ann Rheum Dis       Date:  2007-07-27       Impact factor: 19.103

10.  Evidence for uncoupling of inflammation and joint remodeling in a mouse model of spondylarthritis.

Authors:  Rik J U Lories; Inge Derese; Cosimo de Bari; Frank P Luyten
Journal:  Arthritis Rheum       Date:  2007-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.